Royalty Pharma (RPRX) Cash from Investing Activities (QoQ) (2019 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Cash from Investing Activities (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn |
| 10 | Metalla Royalty & Streaming | 942.93 Mn | 931.86 Mn | 4.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.93% |
| Mar 31, 2026 | 43.63% |
| Dec 31, 2025 | 11.53% |
| Sep 30, 2025 | -207.17% |
| Jun 30, 2025 | -161.91% |
| Mar 31, 2025 | 199.67% |
| Dec 31, 2024 | 57.61% |
| Sep 30, 2024 | -33.53% |
| Jun 30, 2024 | -930.79% |
| Mar 31, 2024 | 91.34% |
| Dec 31, 2023 | -121.94% |
| Sep 30, 2023 | -610.45% |
| Jun 30, 2023 | 88.64% |
| Mar 31, 2023 | -234.67% |
| Dec 31, 2022 | 129.10% |
| Sep 30, 2022 | -4,622.48% |
| Jun 30, 2022 | -370.29% |
| Mar 31, 2022 | 102.02% |
| Dec 31, 2021 | 34.76% |
| Sep 30, 2021 | -770.15% |